MEAD
Dead / Abandoned — Abandoned — failure to respond (as of 12 Sept 2019)
What this means for you
This application is over — abandoned 15 Aug 2019. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88188384
- Mark type
- Stylized text
- Filed
- 09 Nov 2018
- Abandoned
- 15 Aug 2019
- Attorney of record
- Chelsea E. Carbone
Goods and services
- Class 005 — Pharmaceuticals: Dietary and nutritional supplements; dietary and nutritional supplements used for dialysis; dietary and nutritional supplements for treating cancer; dietary and nutritional supplements for use in connection with a variety of therapeutic areas; dietary and nutritional supplements designed to remediate nutrient deprivation; dietary and nutritional supplements designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer, autoimmune and inflammatory diseases; dietary and nutritional supplements for use in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics
- Class 042 — Scientific and technological services: Dietary and nutritional supplement research services; dietary and nutritional supplement research and development; research and development in dietary and nutritional supplements for the purpose of treating cancer; providing medical and scientific research information in the field of dietary and nutritional supplements; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to dietary and nutritional supplements; dietary and nutritional supplement research in the field of dialysis; dietary and nutritional supplement research in immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, and geriatrics; providing medical and scientific research information in the field of dietary and nutritional supplements and clinical trials; dietary and nutritional supplement research, namely, research relating to remediating nutrient deprivation for use in connection with a wide variety of therapeutic areas
Owner
- Filtricine, Inc., Mountain View, CA, US
Prosecution history
- 12 Sept 2019 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 12 Sept 2019 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 14 Feb 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Feb 2019 — NON-FINAL ACTION E-MAILED
- 14 Feb 2019 — NON-FINAL ACTION WRITTEN
- 14 Feb 2019 — ASSIGNED TO EXAMINER
- 27 Nov 2018 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 Nov 2018 — NEW APPLICATION ENTERED